Acute myeloid leukaemia (AML)

Acute myeloid leukaemia (AML) is a form of leukaemia that progresses quickly and aggressively and usually requires immediate treatment. Myeloid cells have two important roles in the human body. First, they fight against bacterial infections and at the same time they prevent the spread of tissue damage. Symptoms can include tiredness, shortness of breath, easy bruising and bleeding, and an increased risk of infection.

Showing all 2 results

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price from
Gemtuzumab ozogamicin FM3513	CD33	Antibody-drug conjugate (ADC)	Mylotarg®	1 mg/mL	–	0,1 mg	-80°C	08/2024	1.127,00 €	view product Max: 10 Min: 1 Step: 1
Gemtuzumab ozogamicin GL8910	CD33	Antibody-drug conjugate (ADC)	Mylotarg®	1 mg/mL	–	0,1 mg	-80°C	03/2025	1.127,00 €	view product Max: 10 Min: 1 Step: 1